Department of Pharmaceuticals invites applications under PLI scheme to produce Vitamin B1

Published On 2022-08-04 11:02 GMT   |   Update On 2022-08-04 11:02 GMT
Advertisement

Promoting the Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country, the Department of Pharmaceuticals (DoP) has invited application for the eligible product Vitamin B1, through the chemical synthesis route under Production of Linked Incentive (PLI) scheme.

This came in response to the decision made at the Empowered Committee (EC) meeting on June 3, 2012, to seek applications for the eligible product Vitamin B1 made by the chemical synthesis process.

Advertisement

For more details, check out the full story on the link below:

DoP Invites Applications Under PLI Scheme To Produce Vitamin B1, Details


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News